Multi-scale Computational Models of Pro-angiogenic Treatments in Peripheral Arterial Disease
暂无分享,去创建一个
[1] N. Banchero,et al. The distribution of diffusion distances in the gastrocnemius muscle of various mammals during maturation , 1982, Pflügers Archiv.
[2] Y. Kan,et al. Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[3] Aleksander S Popel,et al. A computational model of intracellular oxygen sensing by hypoxia-inducible factor HIF1α , 2006, Journal of Cell Science.
[4] T. Skalak,et al. The FASEB Journal express article 10.1096/fj.03-0933fje. Published online February 6, 2004. Multicellular simulation predicts microvascular patterning and in silico tissue assembly , 2022 .
[5] Henning Langberg,et al. Exercise but not Prostanoids Enhance Levels of Vascular Endothelial Growth Factor and other Proliferative Agents in Human Skeletal Muscle Interstitium , 2003, The Journal of physiology.
[6] P. Lloyd,et al. Angiogenic growth factor expression in rat skeletal muscle in response to exercise training. , 2003, American journal of physiology. Heart and circulatory physiology.
[7] S. Rajagopalan,et al. Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial. , 2003, American heart journal.
[8] O. Hudlická,et al. Hypoxia and Expression of Vegf‐A Protein in Relation to Capillary Growth in Electrically Stimulated Rat and Rabbit Skeletal Muscles , 2002, Experimental physiology.
[9] M. Flessner,et al. In vivo diffusion of immunoglobulin G in muscle: effects of binding, solute exclusion, and lymphatic removal. , 1997, American journal of physiology. Heart and circulatory physiology.
[10] V. Cristini,et al. Nonlinear simulation of tumor necrosis, neo-vascularization and tissue invasion via an adaptive finite-element/level-set method , 2005, Bulletin of mathematical biology.
[11] J. Regensteiner,et al. Current medical therapies for patients with peripheral arterial disease: a critical review. , 2002, The American journal of medicine.
[12] Seng H. Cheng,et al. Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. , 2005, American journal of physiology. Cell physiology.
[13] W. Schaper,et al. Collateral Artery Growth (Arteriogenesis) After Experimental Arterial Occlusion Is Impaired in Mice Lacking CC-Chemokine Receptor-2 , 2004, Circulation research.
[14] E. Rebar,et al. Engineered Zinc Finger–Activating Vascular Endothelial Growth Factor Transcription Factor Plasmid DNA Induces Therapeutic Angiogenesis in Rabbits With Hindlimb Ischemia , 2004, Circulation.
[15] P. Quax,et al. Vascular Endothelial Growth Factor Overexpression in Ischemic Skeletal Muscle Enhances Myoglobin Expression In Vivo , 2004 .
[16] E. Weibel,et al. Capillary tortuosity in skeletal muscles of mammals depends on muscle contraction. , 1989, Journal of applied physiology.
[17] T. Osawa,et al. Comparison of the thickness of basement membranes in various tissues of the rat. , 2003, Journal of Electron Microscopy.
[18] B. J. Limberg,et al. Vascular endothelial growth factor receptor-2 and neuropilin-1 form a receptor complex that is responsible for the differential signaling potency of VEGF(165) and VEGF(121). , 2001, The Journal of biological chemistry.
[19] Benjamin J. Kraus,et al. Impaired Revascularization in a Mouse Model of Type 2 Diabetes Is Associated With Dysregulation of a Complex Angiogenic-Regulatory Network , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[20] Napoleone Ferrara,et al. Angiogenesis as a therapeutic target , 2005, Nature.
[21] D. Desplanches,et al. Effect of spontaneous recovery or retraining after hindlimb suspension on aerobic capacity. , 1987, Journal of applied physiology.
[22] J. Isner,et al. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. , 1999, The American journal of pathology.
[23] K. Ward,et al. Resonance Raman spectroscopy: A new technology for tissue oxygenation monitoring* , 2006, Critical care medicine.
[24] E. Crivellato,et al. Angiogenesis in rheumatoid arthritis. , 2006, Histology and histopathology.
[25] S. Egginton,et al. Association between Shear Stress, Angiogenesis, and VEGF in Skeletal Muscles In Vivo , 2001, Microcirculation.
[26] Jeffrey A Hubbell,et al. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[27] Shay Soker,et al. VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor binding , 2002, Journal of cellular biochemistry.
[28] Aleksander S Popel,et al. Differential binding of VEGF isoforms to VEGF receptor 2 in the presence of neuropilin-1: a computational model. , 2005, American journal of physiology. Heart and circulatory physiology.
[29] K. Alitalo,et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia , 2003, The Journal of cell biology.
[30] S. Harper,et al. VEGF165b, an endogenous C-terminal splice variant of VEGF, inhibits retinal neovascularization in mice. , 2006, Molecular vision.
[31] A. Popel,et al. Interactions of VEGF isoforms with VEGFR-1, VEGFR-2, and neuropilin in vivo: a computational model of human skeletal muscle. , 2007, American journal of physiology. Heart and circulatory physiology.
[32] T. K. Hunt,et al. Correlation of a simple direct measurement of muscle pO(2) to a clinical ischemia index and histology in a rat model of chronic severe hindlimb ischemia. , 2002, Journal of vascular surgery.
[33] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[34] G. Hughes,et al. Angiogenic therapy for coronary artery and peripheral arterial disease , 2005, Expert review of cardiovascular therapy.
[35] H. Haider,et al. Therapeutic Angiogenesis for Treatment of Peripheral Vascular Disease , 2004, Growth factors.
[36] H. Blau,et al. Critical role of microenvironmental factors in angiogenesis , 2005, Current atherosclerosis reports.
[37] J. Ferziger. Numerical methods for engineering application , 1981 .
[38] J. Huh,et al. Efficient expression of the vascular endothelial growth factor gene in vitro and in vivo, using an adeno-associated virus vector. , 2001, Journal of molecular and cellular cardiology.
[39] J. Pearlman,et al. Impact of Mouse Strain Differences in Innate Hindlimb Collateral Vasculature , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[40] A. Whittemore. Presidential address: a team for the 21st century: the vascular center. , 2000, Journal of vascular surgery.
[41] A. Fuglevand,et al. Oxygen delivery to skeletal muscle fibers: effects of microvascular unit structure and control mechanisms. , 2003, American journal of physiology. Heart and circulatory physiology.
[42] Hendrik B. Sager,et al. Collateral arteries grow from preexisting anastomoses in the rat hindlimb. , 2002, American journal of physiology. Heart and circulatory physiology.
[43] S. Egginton,et al. Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity. , 2003, Clinical science.
[44] Aleksander S Popel,et al. A computational model of oxygen transport in skeletal muscle for sprouting and splitting modes of angiogenesis. , 2006, Journal of theoretical biology.
[45] Imo E. Hoefer,et al. Role of Ischemia and of Hypoxia-Inducible Genes in Arteriogenesis After Femoral Artery Occlusion in the Rabbit , 2001, Circulation research.
[46] A. Popel,et al. Dimerization of VEGF receptors and implications for signal transduction: a computational study. , 2007, Biophysical chemistry.
[47] Shuyu Sun,et al. A deterministic model of growth factor-induced angiogenesis , 2005, Bulletin of mathematical biology.
[48] B. J. Limberg,et al. Vascular Endothelial Growth Factor Receptor-2 and Neuropilin-1 Form a Receptor Complex That Is Responsible for the Differential Signaling Potency of VEGF165 and VEGF121 * , 2001, The Journal of Biological Chemistry.
[49] M. Gassmann,et al. HIF and VEGF relationships in response to hypoxia and sciatic nerve stimulation in rat gastrocnemius , 2004, Respiratory Physiology & Neurobiology.
[50] Aleksander S Popel,et al. Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise. , 2007, American journal of physiology. Heart and circulatory physiology.
[51] E. Paleolog. Angiogenesis in rheumatoid arthritis , 2002, Arthritis research.
[52] G. Semenza,et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O 2 tension , 2002 .
[53] O. Hudlická,et al. A New Model of Peripheral Arterial Disease: Sustained Impairment of Nutritive Microcirculation and Its Recovery by Chronic Electrical Stimulation , 2005, Microcirculation.
[54] A. Pries,et al. Microvascular blood viscosity in vivo and the endothelial surface layer. , 2005, American journal of physiology. Heart and circulatory physiology.
[55] A. Popel,et al. Model of competitive binding of vascular endothelial growth factor and placental growth factor to VEGF receptors on endothelial cells. , 2004, American journal of physiology. Heart and circulatory physiology.
[56] M. Simons,et al. Growth factor-induced therapeutic angiogenesis in the heart: protein therapy. , 2005, Cardiovascular research.
[57] S. Ylä-Herttuala,et al. HIF-VEGF-VEGFR-2, TNF-alpha and IGF pathways are upregulated in critical human skeletal muscle ischemia as studied with DNA array. , 2004, Atherosclerosis.
[58] Jennifer L. Doyle,et al. Regulators of angiogenesis and strategies for their therapeutic manipulation. , 2006, The international journal of biochemistry & cell biology.
[59] O. Mathieu-Costello,et al. Differential microvascular response to disuse in rat hindlimb skeletal muscles. , 1999, Journal of applied physiology.
[60] K. Peters,et al. Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. , 2004, Journal of applied physiology.
[61] Lena Claesson-Welsh,et al. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. , 2006, Experimental cell research.
[62] Holger Gerhardt,et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. , 2002, Genes & development.
[63] P. Campochiaro,et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1 , 2006, Gene Therapy.
[64] Brian H Annex,et al. Plasticity of myocytes and capillaries: a possible coordinating role for VEGF. , 2004, Circulation research.
[65] Napoleone Ferrara,et al. VEGF as a Therapeutic Target in Cancer , 2005, Oncology.
[66] R. Rutherford,et al. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). , 2000, Journal of vascular surgery.
[67] G. Semenza,et al. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. , 1996, The American journal of physiology.
[68] H. T. Yang,et al. What makes vessels grow with exercise training? , 2004, Journal of applied physiology.
[69] H. Blau,et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. , 2004, The Journal of clinical investigation.
[70] Christopher G Ellis,et al. Automated Method for Tracking Individual Red Blood Cells Within Capillaries to Compute Velocity and Oxygen Saturation , 2005, Microcirculation.
[71] P. Quax,et al. Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. , 2004, Circulation research.
[72] Aleksander S Popel,et al. VEGF gradients, receptor activation, and sprout guidance in resting and exercising skeletal muscle. , 2007, Journal of applied physiology.